Art

J-GLOBAL ID：201802249357985227   Reference number：18A1111033

Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

頭頸部の再発性または転移性扁平上皮癌におけるニボルマブ対研究者の選択:腫瘍PD-L1発現による分析を伴うチェックメイト141の長期生存更新【JST・京大機械翻訳】

Author (21)： Ferris Robert L. (University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA) ,  Blumenschein George (MD Anderson Cancer Center, Houston, TX, USA) ,  Fayette Jerome (Centre Leon Berard, Lyon, France) ,  Guigay Joel (Centre Antoine Lacassagne, FHU OncoAge, Universite Cote d’Azur, Nice, France) ,  Colevas A. Dimitrios (Stanford University, Stanford, CA, USA) ,  Licitra Lisa (Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy) ,  Harrington Kevin J. (Royal Marsden NHS Foundation Trust/The Institute of Cancer Research National Institute of Health Research Biomedical Research Centre, London, UK) ,  Kasper Stefan (West German Cancer Center, University Hospital, Essen, Germany) ,  Vokes Everett E. (University of Chicago Medical Center, Chicago, IL, USA) ,  Even Caroline (Gustave Roussy, Villejuif Cedex, France) ,  Worden Francis (University of Michigan, Ann Arbor, MI, USA) ,  Saba Nabil F. (Winship Cancer Institute of Emory University, Atlanta, GA, USA) ,  Docampo Lara Carmen Iglesias (Hospital Universitario 12 de Octubre, Madrid, Spain) ,  Haddad Robert (Dana-Farber/Harvard Cancer Center, Boston, MA, USA) ,  Rordorf Tamara (Universitaetsspital Zurich, Zurich, Switzerland) ,  Kiyota Naomi (Kobe University Hospital, Kobe, Japan) ,  Tahara Makoto (National Cancer Center Hospital East, Kashiwa, Japan) ,  Lynch Mark (Bristol-Myers Squibb, Princeton, NJ, USA) ,  Jayaprakash Vijayvel (Bristol-Myers Squibb, Princeton, NJ, USA) ,  Li Li (Bristol-Myers Squibb, Princeton, NJ, USA) ,  Gillison Maura L. (MD Anderson Cancer Center, Houston, TX, USA)
Material： Oral Oncology  (Oral Oncol)
Volume： 81  Page： 45-51  Publication year： 2018 
JST Material Number： A1166A  ISSN： 1368-8375  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： We report 2-year results from ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1111033&from=J-GLOBAL&jstjournalNo=A1166A") }}

Thesaurus term： *squamous cell carcinoma ,  safety ,  follow-up study ,  *tumor ,  *recurrence ,  patient ,  human(primates)
Semi thesaurus term： 有害事象 ,  エンドポイント ,  腫瘍進行 ,  *転移性 ,  *長期生存 ,  *CD274抗原 ,  *ニボルマブ , 【Automatic Indexing@JST】

Author keywords (10)： Nivolumab ,  Head and Neck Neoplasms ,  Carcinoma squamous cell of head and neck ,  Immunotherapy ,  Papillomaviridae (HPV Human Papillomavirus Viruses) ,  Programmed Cell Death 1 Receptor ,  CD274 protein human (PD-L1 Protein Human) ,  Clinical Trial Phase III ,  Survival Analysis ,  Survivors (Long-term Survivors)

JST classification (4)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of ear,nose,pharynx and larynx  (GQ04000E) ,  Tumors(=neoplasms)of female genitalia and fetus  (GS04000K) ,  Tumors(=neoplasms)of digestive system  (GH04000D)

Terms in the title (12)： 頭頸部 ,  再発 ,  転移性扁平上皮癌 ,  ニボルマブ ,  研究 ,  腫瘍 ,  PD-L1 ,  発現 ,  分析 ,  長期 ,  生存 ,  更新